RxDoctor Payments Data

Lashauna McIntosh, MD

Obstetrics & Gynecology · Newark, DENPI 1457350654

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,105 of the $1,601 with a category attached, or 69.0%. 19 manufacturers reported payments, led by Pfizer at 32.8% of the total. Reporting peaked in 2019 at $449 and has fallen 94.5% since, to $25 in 2025.

$1,601in general payments, 2019–2025

Across 60 payments — averaging $26.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$525
  • AbbVie$203
  • Intuitive Surgical$145
  • Astellas Pharma US Inc$127
  • Novo Nordisk$123
  • Therapeuticsmd, Inc.$74
  • plus $405 from 13 others

What the payments were for

  • Speaking & faculty fees$35022%
  • Food & beverage$1,10569%
  • Education$1469%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,601 in reported general payments places this provider in the 75th percentile of 139 obstetrics & gynecology providers in Delaware.

See all obstetrics & gynecology providers in Delaware

Medicare billing

Part B allowed, 2024
$11,922
Medicare patients
116
Services billed
209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol15$1,096
Alendronate Sodium22$287
Fluconazole12$34

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →